BDRXBiodexa Pharmaceuticals plc American Depositary Shs

ADRCNasdaq (XNAS)·USD

Identity

Security key: 12377
Ticker: BDRX
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-12-07
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BDRX

Detail

Enriched 2026-08-14 20:47

Market cap: $1,543,599
Shares outstanding (class): 1,029,066
Shares outstanding (weighted): 1,029,066
SIC: —
Employees: 11
Location: —
Homepage: https://www.biodexapharma.com
Description: Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Market cap and share counts drift.

Funds holding this security

as of 2026-03-31

No reported positions at this date.

Positions are reached through OpenFIGI-resolved ISINs. A security with no resolved ISIN cannot be found this way even if funds do hold it.

Funds holding this security

Identifiers

master.security_identifier

TICKERBDRX
FIGI_COMPOSITEBBG00BLVW2R4
FIGI_SHARE_CLASSBBG00BLVW3G4
CIK0001643918

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Biodexa Pharmaceuticals is a biopharmaceutical company, so it is classified as equity in the healthcare sector, specifically pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.